We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+7.59%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$222M
AUM Growth
-$48.8M
Cap. Flow
-$57.8M
Cap. Flow %
-26.1%
Top 10 Hldgs %
90.89%
Holding
28
New
6
Increased
2
Reduced
7
Closed
4

Top Buys

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$25.2M
2
BLUE
bluebird bio
BLUE
+$10.2M
3
LENS
Presbia PLC Ordinary Shares
LENS
+$2.57M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.52M
5
FBIO icon
Fortress Biotech
FBIO
+$1.39M

Top Sells

Rank Stock Value
1
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$39.9M
2
RLYP
RELYPSA INC COM
RLYP
+$15.1M
3
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$13.9M
4
DYAX
DYAX CORPORATION
DYAX
+$8.51M
5
XNPT
XENOPORT, INC.
XNPT
+$7.39M

Sector Composition

Rank Sector Weight
1 Healthcare 65.59%
2 Consumer Discretionary 0.01%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNDA icon
26
Vanda Pharmaceuticals
VNDA
$321M
– –
-500,000
Closed -$7.16M
NVRO
27
DELISTED
NEVRO CORP.
NVRO
– –
-15,356
Closed -$594K
XNPT
28
DELISTED
XENOPORT, INC.
XNPT
– –
-842,568
Closed -$7.39M
1
2

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $9.92B AUM 21.52% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

RTW Investments's Q1 2015 Portfolio in Review

As of Q1 2015, RTW Investments held 28 positions worth $222M, down 18% from $270M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

RTW Investments withdrew a net $57.8M in Q1 2015, closing 4 positions and reducing 7 holdings. Its most notable exit was XENOPORT, INC., an estimated $7.39M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 68% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, RTW Investments opened a new position in Kite Pharma, Inc. worth $21.7M.

  • RTW Investments's largest Q1 2015 buy was Kite Pharma, Inc.: 375,623 shares worth $21.7M.
  • RTW Investments added most to Alnylam Pharmaceuticals in Q1 2015, an estimated $1.52M increase.
  • RTW Investments's biggest Q1 2015 reduction was Taro Pharmaceutical Industries Ltd., cutting an estimated $39.9M.
  • RTW Investments fully exited XENOPORT, INC. in Q1 2015, selling an estimated $7.39M.
  • RTW Investments's ten largest holdings make up 91% of its $222M portfolio in Q1 2015.
  • RTW Investments opened 6 new positions and closed 4 in Q1 2015.
  • RTW Investments's portfolio value fell 18% quarter-over-quarter to $222M.

Based on RTW Investments's 13F filing for Q1 2015, filed 21 May 2015.